Summary

Overview
The Global Intracardiac Oximeters Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing with a CAGR of XX% during the forecast period 2023-2030.
Intracardiac oximetry involves inserting a specialized oxygen-sensing catheter right into the heart's chambers. This technique enables medical professionals to gauge the oxygen content of blood as it enters and leaves the heart because it provides a more direct and precise measurement of oxygen levels within the heart itself.
In critical care settings, such as during cardiac operations, in the treatment of seriously ill patients, or when accurate monitoring of oxygen levels in the heart is necessary, intracardiac oximetry is frequently employed. It is usually carried out by medical specialists and is not a common or non-invasive measurement.
Healthcare professionals are adopting these technologies as a result of ongoing developments in medical technology that have produced more precise and dependable intracardiac oximetry devices. Because older people are more prone to heart diseases, there is an increased demand for cardiac monitoring equipment, such as intracardiac oximeters.
Market Dynamics: Drivers
The Increasing Cardiovascular Disease
Cardiovascular diseases (CVDs) continue to be the world's leading cause of death and significantly increase the expenses of the healthcare system. Cardiovascular diseases (CVDs) are the biggest cause of death worldwide, according to the WHO report from 2021. According to estimates, 17.9 million deaths worldwide in 2019 were attributable to CVDs, or 32% of all fatalities. Heart attack and stroke deaths accounted for 85% of these fatalities.
Cardiovascular disorders, which include illnesses of the heart and circulatory system, impact a huge number of people; as a result, it is essential to develop appropriate diagnostic and monitoring techniques for these patients.
The body's tissues and cells receive oxygen and nourishment via the circulatory system. For cellular physiological function, a sufficient balance between oxygen delivery and consumption must be maintained. After open-heart surgery, accurate and real-time monitoring of particular intracardiac and main vascular oxygen saturations is crucial for the treatment of patients, especially those with cyanotic congenital heart abnormalities.
Current fiber-optic catheter oximeters transfer light from an external source to the blood at the tip of the catheter using hard glass fiber waveguides, and they also transmit some of the backscattered light back to an external unit for detection.
High Cost of Intracardiac Oximeters
Healthcare facilities may be reluctant to invest in intracardiac oximetry technology because of its high cost, especially in environments with limited resources. In some areas or healthcare facilities, access to cutting-edge medical equipment, such as intracardiac oximeters, may be restricted, which could result in inequities in patient care. Medical device approvals and market introduction may be delayed by strict regulatory restrictions. For producers, following regulations may be a challenge.
Segment Analysis
The global intracardiac oximeters market is segmented based on product type, technology, end-user and region.
The reusable intracardiac oximeters segment accounted for approximately 54.7% of the market share
The oxygen saturation (oxygen levels) within the heart chambers is primarily monitored with reusable intracardiac oximeters during cardiac procedures and interventions. To make sure that the heart is getting enough oxygen throughout procedures, it is imperative to have this information. These oximeters are often made as catheters or probes that can be placed into the heart chambers and have sensors on them.
They come with optical sensors that can gauge blood oxygen levels. Since they are meant to be reused, effective sterilizing techniques are necessary to avoid infection and guarantee patient safety. The sterilization and maintenance instructions for these devices are provided by the manufacturers.
These oximeters are frequently employed during cardiac procedures like coronary artery bypass grafting (CABG), valve replacement surgeries, and other heart-related operations. Particularly when the heart is momentarily halted or altered during surgery, they aid in monitoring and controlling oxygen levels.
The surgical team is able to closely monitor the patient's oxygen levels in real-time thanks to the data acquired by intracardiac oximeters being presented on monitoring equipment. Any considerable departure from the norm may warrant the necessary interventions.
Geographical Analysis
North America segment accounted for approximately 41.3% of the market share
North America has been a dominant force in the global intracardiac oximeters market. Intracardiac oximeter business has increased as a result of earlier detection and treatment of heart-related problems due to increased cardiac health awareness and improved diagnostic capabilities. Due to their quicker recovery times and decreased risk, minimally invasive procedures have become more popular. The widespread use of intracardiac oximeters in these operations contributes to their increased popularity.
According to the Centers for Disease Control and Prevention, for men, women, and members of the majority of racial and ethnic groups in the United States, heart disease is the leading cause of mortality. In the US, cardiovascular disease claims one life every 33 seconds. In the United States, heart disease caused approximately 695,000 fatalities in 2021, or one death out of every five. The most typical form of heart disease, coronary heart disease will claim the lives of 375,476 persons in 2021. About 5% of persons who are 20 years of age and older have CAD.
COVID-19 Impact Analysis
The outbreak of the COVID-19 pandemic in late 2019 created unprecedented challenges for industries worldwide, including the global intracardiac oximeters market. Equipment used in critical care and monitoring, especially cardiac care devices, had an increase in demand during the COVID-19 pandemic. The demand for intracardiac oximeters and similar monitoring devices may have increased as a result of hospitals and healthcare facilities need to improve their capacity to care for critically ill patients.
Healthcare resources were redirected to combating the pandemic, which included treating COVID-19 patients and immunizing people. The investment in and adoption of medical innovations unrelated to the pandemic may have been hampered by this reallocation of funds and priorities.
By Product Type
• Disposable Intracardiac Oximeters
• Reusable Intracardiac Oximeters
Technology Type
• Continuous Monitoring Oximeters
• Spot-check Oximeters
By End-user
• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Edwards Lifesciences Corporation, Medtronic, Terumo Cardiovascular Systems Corporation, and others.
Why Purchase the Report?
• To visualize the global intracardiac oximeters market segmentation based on product type, technology, end-user, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous intracardiac oximeters market-level data points with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global intracardiac oximeters market report would provide approximately 43 tables, 49 figures, and 186 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

ページTOPに戻る

Table of Contents

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Product Type
3.2. Snippet by Technology
3.3. Snippet by End-user
3.4. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Increasing Cardiovascular Disease
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1. High Cost of Intracardiac Oximeters
4.1.2.2. XX
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. SWOT Analysis
5.7. Patent Analysis
5.8. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Disposable Intracardiac Oximeters*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Reusable Intracardiac Oximeters
8. By Technology
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
8.1.2. Market Attractiveness Index, By Technology
8.2. Continuous Monitoring Oximeters*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Spot-check Oximeters
9. By End-user
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
9.1.2. Market Attractiveness Index, By End-user
9.2. Hospitals and Clinics*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Others
10. By Region
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. UK
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia-Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-user
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Edwards Lifesciences Corporation*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Medtronic
12.3. Terumo Cardiovascular Systems Corporation
12.4. XX
12.5. XX
12.6. XX
12.7. XX
12.8. XX
12.9. and Others
LIST NOT EXHAUSTIVE
13. Appendix
13.1. About Us and Services
13.2. Contact Us